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We describe how CIITA exerts a dual role against retroviral
infection. The first, classical role is the upregulation of
MHC class II expression and thus the capacity to present
viral antigens to CD4+ T cells. The other, evolutionary
new and fundamental role is to inhibit viral replication by
blocking specifically the function of the viral transactiva-
tors. HIV-1 Tat is inhibited through the competition for
cyclin T1 of the P-TEFb complex, whereas HTLV-2 Tax-2 is
inhibited through a concerted action which may increase
the binding affinity of the CIITA-NFY complex for Tax-2,
displacing it from the viral LTR promoter. As expected,
two distint sequences in the N-term region of CIITA medi-
ate the inhibitory action on Tat and Tax-2, respectively. Of
note, Tax-1 from HTLV-1 seems also to be inhibited by the
same sequence that inhibits HTLV-2 Tax-2. Interestingly,
only those CIITA fragments containing the minimal
inhibitory domains that localize into the nucleus could
exert an effective suppressive action. Taken together, our
results indicate that CIITA is an extant molecular tool
endowed with distinct evolving functions against retrovi-
ruses. These distinct properties of CIITA will shed new
light on the molecular mechanisms of adaptive coevolu-
tion of hosts and pathogens and may be exploited to
envisage novel therapeutic strategies aimed at counteract-
ing retroviral infections.
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